Erythromycin in the management of troublesome BCG lesions

Abstract We have recently seen six persons with troublesome post-BCG lesions. All lesions healed whilst on therapy with erythromycin for a period of 2–4 weeks. Erythromycin has some effect on the atypical mycobacteria (Wolinsky et al. 1957) but its use has not previously been described for treatment of BCG lesions.